Extracorporeal Membrane Oxygenation Market Size | Report 2028

report image

Extracorporeal Membrane Oxygenation Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality (Venoarterial extracorporeal membrane oxygenation, Venovenous extracorporeal membrane oxygenation, and Arteriovenous extracorporeal membrane oxygenation), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates)

Publication Month: Nov 2022 | Report Code: TIPHE100001219 | No. of Pages: 162 | Category: Medical Device | Status: Published

The global extracorporeal membrane oxygenation market was valued at US$ 546.73 million in 2021 and is projected to reach US$ 677.64 million by 2028. The market is estimated to grow at a CAGR of 3.1% during 2022–2028.

Extracorporeal membrane oxygenation (extracorporeal membrane oxygenation) is a treatment used for blood circulation through an artificial lung. The system helps provide heart-lung bypass route outside the body. This also provides support to patients who need a lung transplant. The extracorporeal membrane oxygenation market growth is attributed to the rising prevalence of cardiovascular diseases and respiratory failures and the growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures. However, complications associated with extracorporeal membrane oxygenation hinder the growth of the market.

Strategic Insights

Report Coverage - Extracorporeal Membrane Oxygenation Market
Report CoverageDetails
Market Size Value inUS$ 546.73 Million in 2021
Market Size Value byUS$ 677.64 Million by 2028
Growth rateCAGR of 3.1% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
No. of Pages162
No. of Tables84
No. of Charts & Figures72
Historical data availableYes
Segments coveredModality, Application, and Age Group
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Lucrative Regions in Extracorporeal Membrane Oxygenation Market

Lucrative Regions in Extracorporeal Membrane Oxygenation Market

Get more information on this report :

Market Insights

Growing Adoption of extracorporeal membrane oxygenation in Lung Transplantation Procedures Drive extracorporeal membrane oxygenation Market Growth

Lung transplantation is a life-saving treatment option for patients suffering from end-stage lung diseases, such as COPD, Idiopathic pulmonary fibrosis (IPF), and cystic fibrosis, to improve the quality of life. extracorporeal membrane oxygenation is a versatile tool used in all lung transplantation phases, such as preoperative, intraoperative, and postoperative periods. It acts as a bridge for patient undergoing lung transplantation. Therefore, the adoption of extracorporeal membrane oxygenation during lung transplantation is growing rapidly to manage patients with life-threatening lung disease. According to the Scientific Registry of Transplant Recipients (SRTR), ~4,600 lung transplants are performed across the world every year, of which 55% were performed in North America. According to the same source, ~2,759 patients underwent lung transplantation, and ~3,243 patients were added to the lung transplant waiting list in the US. Primary graft dysfunction (PGD) is the leading cause of death after a lung transplant. Thus, extracorporeal membrane oxygenation is used penultimately in treating PGD post lung transplantation. According to National Library Medicine (NLM), in 2022, the overall incidence of PGD is 30%, in which the risk factors include preoperative donor lung ischemia, organ acquisition, preservation techniques, and intraoperative organ implantation and reperfusion. Thus, the demand for extracorporeal membrane oxygenation equipment is growing for treating patients suffering from PGD.

Modality-Based Insights

The global extracorporeal membrane oxygenation market, based on modality, is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. The venoarterial extracorporeal membrane oxygenation segment held the largest share of the market in 2021. Moreover, the same segment is anticipated to register a highest CAGR of 3.8% in the market during the forecast period. Venoarterial (VA) extracorporeal membrane oxygenation supports the patient's heart and lungs by pushing the blood through the circuit without getting through the patient's heart. This type of extracorporeal membrane oxygenation takes blood out of a large vein and back it into a large artery, allowing oxygen-rich blood to circulate through the body even if the heart is too weak to pump. Veno-arterial extracorporeal membrane oxygenation (VA-extracorporeal membrane oxygenation) has been widely applied over the last decade. It is an effective and valuable therapeutic option in refractory cardiogenic shock of various etiologies. It showed promising results in the specific setting of in-hospital cardiac arrest, and survival rates with good neurological outcomes are reported between 20% and 40%.

Extracorporeal Membrane Oxygenation Market, by Modality – 2021 and 2028

Extracorporeal Membrane Oxygenation Market, by Modality – 2021 and 2028

Get more information on this report :

Age Group-Based Insights

Based on age group, the global extracorporeal membrane oxygenation market is segmented into adults, pediatrics and neonates. The adults segment held the largest share of the market in 2021 and is expected to register a CAGR of 3.7% during 2022–2028. The extracorporeal membrane oxygenation help the adult patients suffering from cardiac or respiratory failure. Moreover, the recent technological advancements in extracorporeal membrane oxygenation circuits have led to reduction in the rate of technical issues and complication.

Extracorporeal Membrane Oxygenation – Market Segmentation

The extracorporeal membrane oxygenation market is segmented on the basis of modality, application, age group, and geography. Based on modality, the market is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, arteriovenous extracorporeal membrane oxygenation. Based on application, the extracorporeal membrane oxygenation market is bifurcated into respiratory and cardiology. In terms of end user, the extracorporeal membrane oxygenation market is segmented into adults, pediatrics, and neonates. By geography, the extracorporeal membrane oxygenation market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). 

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios to dominate the extracorporeal membrane oxygenation market share. Moreover, the market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world. The market is anticipated to flourish in the coming years owing to the development of new innovative products by market players.

Company Profiles

  • Terumo Group
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • LivaNova Plc
  • Nipro Medical Corporation
  • Eurosets S.R.L.
  • Getinge AB
  • Braile Biomedica
  • Fresenius Medical Care AG & Co KGaA
  • ABIOMED Inc

Frequently Asked Questions

The global extracorporeal membrane oxygenation market based on modality is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. In 2021, the venoarterial extracorporeal membrane oxygenation segment accounted for the highest share, moreover the same segment is expected to grow faster at a CAGR of 3.8% in the forecast period.
The extracorporeal membrane oxygenation market majorly consists of the players such as Terumo Group, Medtronic Plc. MicroPort Scientific Corporation, LivaNova Plc, Nipro Medical Corporation, Eurosets S.R.L., Getinge AB, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, and ABIOMED Inc.
The complications associated with extracorporeal membrane oxygenation is expected to restrict the market growth during the forecast period
Factors such as the rising prevalence of cardiovascular diseases and respiratory failures and further growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures.
Extracorporeal membrane oxygenation (ECMO) is a treatment used for the circulation of blood through an artificial lung back into the bloodstream. The system enables to provide heart-lung bypass route outside the body. This also provides support to patients who need a lung transplant. The main purpose of extracorporeal membrane oxygenation is to provide oxygen to the body to heal or rest.
The global extracorporeal membrane oxygenation market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 3.9% during the forecast period.

The List of Companies - Extracorporeal Membrane Oxygenation Market

  1. Terumo Group
  2. Medtronic Plc
  3. MicroPort Scientific Corporation
  4. LivaNova Plc
  5. Nipro Medical Corporation
  6. Eurosets S.R.L.
  7. Getinge AB
  8. Braile Biomedica
  9. Fresenius Medical Care AG & Co KGaA
  10. ABIOMED Inc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the extracorporeal membrane oxygenation market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global extracorporeal membrane oxygenation market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPHE100001219
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount